title: Inflammatory bowel disease treatment and non-melanoma skin cancer: a case report.
abstract: Immunosuppressant medications for Inflammatory Bowel Disease can help with both symptoms and disease progression. However, like immunosuppressants used in transplant patients, they are now suspect of contributing to nonmelenoma skin cancer (NMSC). Presented is a case of a 57-year-old Jewish man with Crohn's Disease who was diagnosed with a total of 84 NMSCs. We hope to elucidate the risk of immunosuppressants, particularly the thiopurines, on the development of NMSC.
authors.affiliation: University of Hawai'i Transitional Residency Program, Honolulu, HI, USA.
authors.forename: Jacqueline F
authors.initials: JF
authors.lastname: De Luca
authors.forename: Yun Sun
authors.initials: YS
authors.lastname: Lee
authors.forename: Douglas
authors.initials: D
authors.lastname: Johnson
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology / Q000473:pathology / Q000556:secondary; D003424:Crohn Disease / Q000188:drug therapy* / Q000453:epidemiology; D017809:Fatal Outcome; D006254:Hawaii / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007414:Intestinal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000556:secondary; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D013472:Sunlight / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents; D015122:Mercaptopurine